Avid Bioservices Inc (CDMO)

[bimerkjaere]

CP, you obviously didn't read my post. I don't think pphm will redo a Ph II to convice a partner. What I said was that sometimes phases are redone after a license agreement has been put in place. For example, if the Ph III will be large, and costly trial, the BP may want to redo Ph II to ensure it should be moved to Ph III.

That said, it is not common, and if the FDA give the go-ahead for Ph III, I don't see this happening with bavi.

As far as $500M 'pocket-money', sure that isn't much compared to the cash on hand for a lot of these major pharmas, but that doesn't mean you can just assume any risk. $500M could buy anywhere from 5-10 upfront payments for licensing agreements (much less risky).